Sally Arai, MD
Dr. Arai is an Associate Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center. She earned her medical degree from Geisel School of Medicine at Dartmouth and has been in practice for more than 20 years. She completed her residency from Strong Memorial Hospital and fellowships from Johns Hopkins Hospital and Mount Sinai Medical Center.
Dr. Arai has formal training in clinical research with a Masters in Epidemiology from Stanford University. She has a clinical practice seeing all diseases in hematopoietic cell transplantation, with a clinical research focus on the prevention and treatment of post-transplant complications.
Her research interest includes utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.
Representative Publications:
Final Results From a Defibrotide Treatment-IND Study for Patients With Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Amphiregulin Modifies the Minnesota Acute Graft-Versus-Host Disease Risk Score: Results From BMT CTN 0302/0802
Clinicopathologic Threshold of Acute Colorectal Graft-versus-Host Disease
HLA-Mismatched Unrelated Donor Transplantation Using TLI-ATG Conditioning has a low Risk of GVHD and Potent Antitumor Activity
Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-Vs-Host Disease in Patients With Mycosis Fungoides and Sézary Syndrome
